Why Is Jounce Therapeutics (JNCE) Stock Up 14% Today?


  • Jounce Therapeutics (JNCE) stock is rising after announcing merger plans with Redx Pharma.
  • The two companies will combine in a stock transaction.
  • This would see Redx lead the combined company and change its Nasdaq listing.
JNCE Stock - Why Is Jounce Therapeutics (JNCE) Stock Up 14% Today?

Source: Shutterstock.com

Jounce Therapeutics (NASDAQ:JNCE) stock is on the rise Thursday after the company revealed merger plans with Redx Pharma.

Jounce Therapeutics and Redx Pharma will undergo a merger with an all-stock transaction fueling it. That will have holders of Redx Pharma stock receiving 0.2105 shares of JNCE stock for each share they own.

It’s also worth noting that Jounce Therapeutics plans to enact a reverse stock split while it goes through with the merger plan. This would see it consolidate five shares of JNCE stock into one share. If that happens, the new shares exchange with Redx Pharma would be 0.0421 shares of JNCE stock for each of the company’s shares.

As for ownership of the combined company, holders of Redx Pharma stock will own a 63% stake. The remaining 37% stake of the company will belong to current shareholders of JNCE stock.

More Details About the JNCE Stock Deal

Once the deal between the two companies is complete, the combined company will use the Redx name. It will also trade on the Nasdaq under the REDX stock ticker.

Leading this new company will be current Redx CEO Lisa Anson. Also, Redx chairman Jane Griffiths will take on the role of non-executive chairman of the combined company. The remainder of the Board will be made up of Jounce Therapeutics and Redx Pharma directors.

JNCE stock is up 14.1% as of Thursday morning.

Investors can find more of the latest stock market news below!

We’ve got all of the latest happenings traders need to know about for Thursday! That includes the biggest pre-market stock movers this morning, as well as what’s going on with the housing market, and more. You can find all that news at the following links!

More Thursday Stock Market News

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Article printed from InvestorPlace Media, https://investorplace.com/2023/02/why-is-jounce-therapeutics-jnce-stock-up-14-today/.

©2023 InvestorPlace Media, LLC